CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

by Lim, M., Lin, Y.-J, Mashouf, L.A
Published 2022

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: A Pediatric Real World CAR Consortium Report

by Baggott, C., Brown, P.A, Chinnabhandar, V., Curran, K.J, Egeler, E., Fabrizio, V.A, Hermiston, M., Karras, N.A, Keating, A.K, Krupski, C., Kunicki, M., Laetsch, T.W, Lane, A., Mackall, C.L, Margossian, S.P, Mavroukakis, S., Moskop, A., Myers, G.D, Pacenta, H., Phillips, C.L, Prabhu, S., Qayed, M., Rabik, C.A, Rossoff, J., Satwani, P., Schultz, L.M, Stefanski, H.E, Talano, J.-A, Verneris, M.R, Wilcox, R., Yasemin Goksenin, A.
Published 2022

Single-center experience using anakinra for steroid-refractory immune effector cell-Associated neurotoxicity syndrome (ICANS)

by Chen, Y.-B, Cook, D., Defilipp, Z., Dey, B., El-Jawahri, A.R, Frigault, M.J, Gallagher, K., Horick, N., Leick, M.B, Lindell, K., Maus, M.V, McAfee, S.L, O'Donnell, P., Spitzer, T., Trailor, M., Wehrli, M.
Published 2022